製藥自動化市場規模、佔有率及成長分析（按產品、自動化模式、最終用戶、應用和地區）－2025-2032 年產業預測

2023 年全球製藥自動化市場規模為 75.6 億美元，預計將從 2024 年的 83.8 億美元成長到 2032 年的 190.3 億美元，預測期內（2025-2032 年）的複合年成長率為 10.8%。

由先進的分析和軟體驅動的藥房自動化設備正在改變全球零售藥房的格局，顯著提高盈利和效率。自動化的實施簡化了藥師的工作流程管理，並優先考慮患者滿意度，同時顯著減少藥物浪費並降低每劑成本。隨著處方藥和非處方藥價格上漲，製藥公司正在轉向自動化，以在不影響品質或安全的前提下提高產量。這項技術創新符合彈性自動化和數位化等現有趨勢，這些趨勢在新冠疫情期間得到了支持，從而可以實現更快、更靈活的生產線。總體而言，自動化的推動力正在再形成產業，並使企業在艱難的市場環境中實現永續成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局

製藥自動化市場規模（按產品和複合年成長率） (2025-2032)

• 市場概覽
• 硬體
• 軟體
• 服務

製藥自動化市場規模（依自動化模式和複合年成長率） (2025-2032)

• 市場概覽
• 全自動系統
• 半自動系統

製藥自動化市場規模（依最終用戶和複合年成長率）(2025-2032)

• 市場概覽
• 製藥公司
• 研究部門
• 契約製造組織（CMO）
• 合約研究組織（CRO）

製藥自動化市場規模（按應用和複合年成長率）（2025-2032）

• 市場概覽
• 藥物研發
• 藥物開發
• 臨床試驗
• 製造業
• 包裝
• 品管

製藥自動化市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Becton, Dickinson and Company（USA）
• Baxter International Inc.（USA）
• Siemens Healthineers（Germany）
• GE Healthcare（USA）
• Omnicell, Inc.（USA）
• Swisslog Healthcare（Switzerland）
• Capsa Healthcare（USA）
• Parata Systems（USA）
• ARxIUM（Canada）
• ScriptPro LLC（USA）
• Yuyama Co., Ltd.（Japan）
• McKesson Corporation（USA）
• Pearson Medical Technologies（USA）
• Accu-Chart Plus Healthcare Systems（USA）
• NewIcon（Finland）
• AlixaRx（USA）
• KUKA AG（Germany）
• TOSHO Inc.（Japan）
• Cerner Corporation（USA）

結論和建議

Global Pharmaceutical Automation Market size was valued at USD 7.56 billion in 2023 and is poised to grow from USD 8.38 billion in 2024 to USD 19.03 billion by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

Pharmacy automation devices, powered by advanced analytics and software, are transforming the global retail pharmacy landscape, enhancing profitability and efficiency significantly. The adoption of automation has drastically cut medication waste, lowering the cost per dose, while simplifying workflow management for pharmacists and prioritizing patient satisfaction. In light of skyrocketing prices for prescription and over-the-counter medications, pharmaceutical companies are leveraging automation to boost production without compromising quality or safety. This innovation enables faster and more flexible production line construction, aligning with existing trends like flexible automation and digitalization that gained traction during the COVID-19 pandemic. Overall, the push toward automation is reshaping the industry and positioning companies for sustainable growth amidst challenging market conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Automation Market Segments Analysis

Global Pharmaceutical Automation Market is segmented by Offering, Mode of Automation, End User, Application and region. Based on Offering, the market is segmented into Hardware, Software and Services. Based on Mode of Automation, the market is segmented into Fully-Automated Systems and Semi-Automated Systems. Based on End User, the market is segmented into Pharmaceutical Companies, Research Laboratories, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on Application, the market is segmented into Drug Discovery, Drug Development, Clinical Trials, Manufacturing, Packaging and Quality Control. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Automation Market

The Global Pharmaceutical Automation market is experiencing significant growth due to several key factors. Increasing integration of robotics in pharmaceutical manufacturing, government initiatives aimed at advancing industrial development, and heightened investments focused on upgrading conventional production facilities are driving this trend. Moreover, there is a surging consumer demand for safe and digitized production methods, which further fuels the adoption of automation technologies. This combination of technological advancement and changing market expectations is creating a robust environment for growth within the pharmaceutical automation sector, paving the way for innovative solutions and improved operational efficiencies in the industry.

Restraints in the Global Pharmaceutical Automation Market

The Global Pharmaceutical Automation market faces obstacles, yet it is projected that the significant demand for COVID-19 vaccine production, coupled with the increasing integration of Internet of Things (IoT) technologies in pharmaceutical manufacturing, will create considerable opportunities for industry growth. This trend highlights the dual impact of current healthcare needs and technological advancements, suggesting that while challenges exist, the potential for innovation and expansion in pharmaceutical automation is promising. As companies adapt to meet these demands, the landscape of the market is likely to evolve, offering prospects for improved efficiency and effectiveness in drug manufacturing processes.

Market Trends of the Global Pharmaceutical Automation Market

The global pharmaceutical automation market is experiencing significant growth, driven by an escalating demand for advanced technologies that minimize medication errors and enhance operational efficiency. Increasing regulatory pressure for safety and accuracy in drug production, coupled with a heightened focus on patient safety, is propelling investments in automation solutions. Additionally, the ongoing digital transformation, especially post-pandemic, has led to a surge in the adoption of artificial intelligence and robotics within pharmacies. This convergence of factors is fostering innovative solutions, streamlining workflows, and enabling better inventory management, ultimately contributing to the robust expansion of the pharmaceutical automation landscape worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Pharmaceutical Automation Market Size by Offering & CAGR (2025-2032)

• Market Overview
• Hardware
• Software
• Services

Global Pharmaceutical Automation Market Size by Mode of Automation & CAGR (2025-2032)

• Market Overview
• Fully-Automated Systems
• Semi-Automated Systems

Global Pharmaceutical Automation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Research Laboratories
• Contract Manufacturing Organizations (CMOs)
• Contract Research Organizations (CROs)

Global Pharmaceutical Automation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Drug Development
• Clinical Trials
• Manufacturing
• Packaging
• Quality Control

Global Pharmaceutical Automation Market Size & CAGR (2025-2032)

• North America (Offering, Mode of Automation, End User, Application)
  • US
  • Canada
• Europe (Offering, Mode of Automation, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Mode of Automation, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Mode of Automation, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Mode of Automation, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omnicell, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swisslog Healthcare (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capsa Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parata Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARxIUM (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScriptPro LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yuyama Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pearson Medical Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accu-Chart Plus Healthcare Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NewIcon (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AlixaRx (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KUKA AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TOSHO Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations